| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |